Cell and Tissue Banking

, Volume 6, Issue 4, pp 249–253 | Cite as

Infectious Disease Risk of Cadaveric Tissue Donors Who Used Non-injected Illicit Drugs



This study assessed the correlation between a history of non-injection illicit drug use by cadaveric tissue donors and the presence of markers for Human Immunodeficieny Virus Type 1 (HIV-1), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human T Lymphocyte Virus Types I–II (HTLV-I–II), and Syphilis in their blood. It was found in 12,227 donors recovered in 2000–2002 that 9.68% of individuals with a history of non-injection drug use were seropositive for one or more infectious disease markers compared to 4.26% of donors without a history of drug abuse (p < 0.001). A history of non-injection drug use had a positive predictive value of 9.68% and a negative predictive value of 95.74%. Analysis of seropositivity rates associated with individual drugs indicated that 9.6% of cocaine abusers were positive for one or more markers (p < 0.001). Other drugs exhibited higher rates of seropositivity but the numbers were insufficient for statistical analysis. Other risk factors (transfusion of blood/blood products, tattoos and body piercing, incarceration) were not associated with higher incidence of infectious disease markers.


Allograft safety Non-injection drug use Tissue donation HIV transmission Hepatitus B virus transmission Hepatitis C virus transmission 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Association of Tissue Banks. 2002. Standards for tissue banking. accessed on 4/6/2005 at http://www.aatb.org.Google Scholar
  2. American Association of Tissue Banks and Brubaker S. 2005. Personal communication.Google Scholar
  3. Centers for Disease Control Surveillance Summaries, Youth Risk Behavior Survey – United States 1999. (2000). MMWR 49(SS5): 1–94.Google Scholar
  4. Centers for Disease Control.2002Update: allograft-associated bacterial infections – United StatesMMWR51207210Google Scholar
  5. Centers for Disease Control2003Update: invasive streptococcus pyogenes after allograft implantation – ColoradoMMWR5211731176Google Scholar
  6. Centers for Disease Control. 2003Hepatitis C virus transmission from an antibody-negative organ and tissue donor – United StatesMMWR13273276Google Scholar
  7. Chergwin, K.D.,  et al. 1999Incidence and risk factors for heterosexual acquired HIV in an inner city cohort of womenJ. AIDS Human Retroviruses20295299Google Scholar
  8. Conrad, E.U.,  et al. 1995Transmission of hepatitis C virus by tissue transplantationJ. Bone Joint Surg. Am.77214224PubMedGoogle Scholar
  9. Conry-Cantilena, C.,  et al. 1996Routes of infection, viremia and liver disease in blood donors found to have Hepatitis C infectionN Engl. J. Med.33416911696CrossRefPubMedGoogle Scholar
  10. T. Eastlund 2003. Infectious Disease Transmission through Tissue Transplantation, Advances in Tissue Banking. Vol. 7. World Scientific Publishing Co.Google Scholar
  11. Harsch, H.H.,  et al. 2000Hepatitis C infection in cocaine users – a silent epidemicCommun. Ment. Health J.36225233Google Scholar
  12. Hser, Y.I.,  et al. 1999Cocaine use and high risk sexual behavior among STD clinic patientsSex Transm Dis.268286PubMedGoogle Scholar
  13. National Institutes of Health Consensus Statement1998Hepatology262s10sGoogle Scholar
  14. National Institute on Drug Abuse Research Report Series – Cocaine abuse addiction. . accesses on 4/6/2005 at http://www.nida.nih.gov/ResearchReports/Cocaine/cocaine2.html.Google Scholar
  15. Quaglio, G.,  et al. 2003Factors associated with Hepatitis C virus infection in injection and non-injection drug users in ItalyClin. Infect. Dis.373340CrossRefPubMedGoogle Scholar
  16. Page-Shafer, K.A.,  et al. 2002Hepatitis C infection in young, low income women: role of sexually transmitted infection as a potential cofactor for Hepatitis C infectionAm. J. Pub. Health92670676PubMedCrossRefGoogle Scholar
  17. Samet, J.,  et al. 1999HIV testing in drug abusersAm. J. Drug Alcohol Abuse25269280CrossRefPubMedGoogle Scholar
  18. Simonds, R.J.,  et al. 1992Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donorN. Eng. J. Med.326726732CrossRefGoogle Scholar
  19. United States Food and Drug Administration. 2004. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products. final rule – 5/25/2004 accessed on 4/6/2005 at http://www.fda.gov/cber/tissue/docs.htm.Google Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Musculoskeletal Transplant FoundationEdisonUSA

Personalised recommendations